| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 07/29/2004 | WO2004063181A1 Urea derivatives and their use as anti-inflammatory agents |
| 07/29/2004 | WO2004063163A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 07/29/2004 | WO2004063158A1 2-piperidone derivatives as prostaglandin agonists |
| 07/29/2004 | WO2004063157A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 07/29/2004 | WO2004063150A2 Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process |
| 07/29/2004 | WO2004062601A2 Antibacterial agents |
| 07/29/2004 | WO2004062562A2 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 07/29/2004 | WO2004046091A3 Biaromatic compounds which activate ppar-gama type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/29/2004 | WO2004045533A3 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/29/2004 | WO2004041777A3 Heteroarylpiperidine modulators of chemokine receptor activity |
| 07/29/2004 | WO2004026816B1 Aromatic liver x-receptor modulators |
| 07/29/2004 | WO2003101382A3 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 07/29/2004 | US20040147754 Novel process |
| 07/29/2004 | US20040147746 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147575 Hypotensive agents; cardiovascular disorders |
| 07/29/2004 | US20040147569 Cell differentiation inducer |
| 07/29/2004 | US20040147557 Aryl piperidine derivatives as inducers of ldl-receptor expression |
| 07/29/2004 | US20040147556 Analgesics; anxiolytuic agents; gastrointestinal disorders |
| 07/29/2004 | US20040147555 Anticoagulants; brain disorders; blood circulation disorders; myocardial infraction |
| 07/29/2004 | US20040147553 Efficiency; side effect reduction; antiarthriutic agents; autoimmune diseases |
| 07/29/2004 | US20040147529 Preferentially substituted calcium channel blockers |
| 07/29/2004 | US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/29/2004 | US20040147497 N-formyl derivatives of paroxetine |
| 07/29/2004 | US20040146554 Providing an active pharmaceutical compound; providing a basic salt as one of a powder, a suspension and a solution having a pH greater than 7; combining; delivering the non-enteric coated liquid formulation |
| 07/29/2004 | US20040146542 Non-therapeutical process for deterring vermin from warm-blooded animals, whereby 2-substituted-piperidine compound is is applied topically, together with a spreading additive, to the skin, the pelt or the plumage of the warm-blooded animal |
| 07/29/2004 | US20040146518 Novel opiate compounds, methods of making and methods of use |
| 07/29/2004 | DE69912203T2 Verfahren zur inhibierung der polymerisierung von vinylverbindungen A method for inhibiting the polymerization of vinyl compounds |
| 07/29/2004 | CA2851462A1 Antibacterial agents |
| 07/29/2004 | CA2512582A1 Antibacterial agents |
| 07/29/2004 | CA2512257A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 07/29/2004 | CA2510400A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 07/29/2004 | CA2510382A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 07/28/2004 | EP1440976A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/28/2004 | EP1440118A1 Blends of waxes and polymer additives |
| 07/28/2004 | EP1440067A1 N-formyl derivatives of paroxetine |
| 07/28/2004 | EP1440060A1 4(piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders |
| 07/28/2004 | EP1439834A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| 07/28/2004 | EP1058698B1 Preparation for prevention and healing of inflammation affections |
| 07/28/2004 | EP0990645B1 Novel sulfonamide derivatives |
| 07/28/2004 | EP0831821B1 Optically pure (-) norcisapride for treating digestive tract disorders |
| 07/28/2004 | EP0805816B1 Compounds with growth hormone releasing properties |
| 07/28/2004 | CN1516697A Aromatic dicarboxylic acid derivatives |
| 07/28/2004 | CN1516689A Process for production of piperidine derivative fexofenadine |
| 07/28/2004 | CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/28/2004 | CN1516684A Deuterated N-substituted and alpha-substituted diphenylalkoxy acetic acid amino alkyl esters and medicaments containing these compounds |
| 07/28/2004 | CN1515563A Aryl substituted piperazine for curing benign prostatauxe |
| 07/28/2004 | CN1515556A Intermediate compound for preparing aryl substituted piperazine |
| 07/28/2004 | CN1515553A Piperidine derivative crystal, midbody for preparation and preparing method |
| 07/28/2004 | CN1515548A Oxaminic acid used as thyroid gland receptor ligand and its derivative |
| 07/28/2004 | CN1515541A Method for detecting ligand pair combination by using non-fluorescent marker and its composite |
| 07/28/2004 | CN1515261A Topical medicine composite containing cholinergic drug or calcium channel paralyser |
| 07/28/2004 | CN1159452C Method and compositions for detecting binding of ligand pair using non-fluorescent label |
| 07/28/2004 | CN1159390C Method for improving chargeability of powder coating composition |
| 07/28/2004 | CN1159296C process for preparing 2,2,6,6-tetramethyl-4-piperidylamine compounds as intermediate of optical stabilizer |
| 07/28/2004 | CN1159295C Inhibitors of metalloproteinases |
| 07/28/2004 | CN1159293C 5-aroylnaphthalene derivatives |
| 07/28/2004 | CN1159289C C-terminal modified oxamyl dipetides as inhibitors of the ICE/ced-3 family of cystenine proteases |
| 07/28/2004 | CN1159277C New intermediate for preparation of anti-histamine piperdine derivatives |
| 07/27/2004 | US6768024 Triamine derivative melanocortin receptor ligands and methods of using same |
| 07/27/2004 | US6767915 Substituted piperidines as melanocortin receptor agonists |
| 07/27/2004 | US6767907 For therapy of psychic and neurologic disorders |
| 07/27/2004 | CA2118512C Agents for treating substance abuse disorders |
| 07/22/2004 | WO2004060875A1 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient |
| 07/22/2004 | WO2004060872A1 Factor xa inhibitors |
| 07/22/2004 | WO2004060865A2 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
| 07/22/2004 | WO2004060859A2 Novel amides that activate soluble guanylate cyclase |
| 07/22/2004 | WO2004060371A1 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines |
| 07/22/2004 | WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/22/2004 | WO2004044000A3 Compounds and methods for modulating functions of classical cadherins |
| 07/22/2004 | WO2004037879A3 Monomers containing at least one biaryl unit and polymers and derivatives prepared therefrom |
| 07/22/2004 | WO2003070675A3 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 07/22/2004 | US20040143121 Process for preparation of donepezil |
| 07/22/2004 | US20040143018 Thrombosis; emphysema; antihistamines; cirrhosis; antiarthritic agents; anticancer agenst |
| 07/22/2004 | US20040142999 Novel compounds and compositions as cathepsin inhibitors |
| 07/22/2004 | US20040142993 Viricides |
| 07/22/2004 | US20040142989 Viricides |
| 07/22/2004 | US20040142986 Controlling transforming growth facor; artificial skin; wound healing agents |
| 07/22/2004 | US20040142974 Anxiolytic agents; hypotensive agents; obesity; psychological disorders; schizophrenia; Parkinson's disease; irritable bowel syndrome; incontinence |
| 07/22/2004 | US20040142972 Sleep disorders; side effect reduction ; antihistamine antagonist |
| 07/22/2004 | US20040142969 Bone disorders; osteoporosis; antihistamines; sexual disorders; antiinflammatory agents; antiarthritic agents; vision defects; antiulcer agents |
| 07/22/2004 | US20040142967 Pain maintenance |
| 07/22/2004 | US20040142966 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 07/22/2004 | US20040142965 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 07/22/2004 | US20040142963 Cardiovascular disorders |
| 07/22/2004 | US20040142923 inhibitors of urotensin II |
| 07/22/2004 | US20040142920 acute or chronic transplant rejection or inflammatory or autoimmune diseases |
| 07/22/2004 | CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/21/2004 | EP1439169A1 DIFLUOROALKENE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE SAME, AND INTERMEDIATE THEREFOR |
| 07/21/2004 | EP1438302A1 New sulfonamide derivatives as d3-receptor agonists |
| 07/21/2004 | EP1438292A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 07/21/2004 | EP1438291A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 07/21/2004 | EP1438288A1 Substituted thioacetamides |
| 07/21/2004 | EP1147080B1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
| 07/21/2004 | CN1514829A Novel herbicides |
| 07/21/2004 | CN1514827A 4-imino-N-alkoxy or oxy-polyalkyl-piperidine compounds and their use as polymerization regulators |
| 07/21/2004 | CN1514823A 草酸衍生物 Oxalic acid derivatives |
| 07/21/2004 | CN1513849A Mannitol and sorbierite derivative |
| 07/21/2004 | CN1513838A Pot cooking sythesis method of alipyracole |
| 07/21/2004 | CN1158264C Metabotropic glutamate receptor antagonists for treating central nervous system disease |